Insights

Recent Investments BridgeBio has attracted significant investments from institutions like Norges Bank, Blue Owl Capital, and SEB Group, indicating strong financial backing and potential for collaboration or partnership opportunities.

Oncology Focus The recent launch of BridgeBio Oncology Therapeutics and the development of a KRAS-focused oncology portfolio present targeted sales opportunities for pharmaceutical equipment, services, and partnerships in the oncology sector.

Financial Strength With revenue estimated between $50M to $100M and a funding of $250M, BridgeBio showcases financial stability and growth potential, making them a promising client for high-value product or service offerings.

Biotechnology Research Leader BridgeBio's focus on genetic diseases research positions them as a key player in the biotechnology sector, presenting opportunities for collaborations in research tools, technologies, and genetic therapies.

Strategic Partnerships The collaborations with companies like Blue Owl Capital, Canada Pension Plan Investment Board, and Skandinaviska Enskilda Banken AB suggest a strong network of industry connections, opening doors for strategic partnerships and vendor relationships.

BridgeBio Tech Stack

BridgeBio uses 8 technology products and services including SAS, Docker, Google Docs, and more. Explore BridgeBio's tech stack below.

  • SAS
    Business Intelligence
  • Docker
    Containerization
  • Google Docs
    Documentation Tools
  • Nuxt.js
    Javascript Frameworks
  • Buildout
    Real Estate Marketing
  • Yoast SEO
    Search Engines
  • Bitbucket
    Source Code Management
  • Envoy
    Web And Application Servers

Media & News

BridgeBio's Email Address Formats

BridgeBio uses at least 1 format(s):
BridgeBio Email FormatsExamplePercentage
first.last@bridgebio.comJohn.Doe@bridgebio.com
85%
fl@bridgebio.comJD@bridgebio.com
7%
flast@bridgebio.comJDoe@bridgebio.com
5%
last@bridgebio.comDoe@bridgebio.com
3%

Frequently Asked Questions

Where is BridgeBio's headquarters located?

Minus sign iconPlus sign icon
BridgeBio's main headquarters is located at 421 Kipling St Palo Alto, California US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is BridgeBio's stock symbol?

Minus sign iconPlus sign icon
BridgeBio is a publicly traded company; the company's stock symbol is BBIO.

What is BridgeBio's official website and social media links?

Minus sign iconPlus sign icon
BridgeBio's official website is bridgebio.com and has social profiles on LinkedIn.

How much revenue does BridgeBio generate?

Minus sign iconPlus sign icon
As of June 2024, BridgeBio's annual revenue reached $75M.

What is BridgeBio's SIC code NAICS code?

Minus sign iconPlus sign icon
BridgeBio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BridgeBio have currently?

Minus sign iconPlus sign icon
As of June 2024, BridgeBio has approximately 565 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio: M. O.Chief Regulatory Affairs Officer: A. N.Chief Legal Officer: D. W.. Explore BridgeBio's employee directory with LeadIQ.

What industry does BridgeBio belong to?

Minus sign iconPlus sign icon
BridgeBio operates in the Biotechnology Research industry.

What technology does BridgeBio use?

Minus sign iconPlus sign icon
BridgeBio's tech stack includes SASDockerGoogle DocsNuxt.jsBuildoutYoast SEOBitbucketEnvoy.

What is BridgeBio's email format?

Minus sign iconPlus sign icon
BridgeBio's email format typically follows the pattern of . Find more BridgeBio email formats with LeadIQ.

How much funding has BridgeBio raised to date?

Minus sign iconPlus sign icon
As of June 2024, BridgeBio has raised $250M in funding. The last funding round occurred on Mar 05, 2024.

When was BridgeBio founded?

Minus sign iconPlus sign icon
BridgeBio was founded in 2014.
BridgeBio

BridgeBio

Biotechnology ResearchCalifornia, United States201-500 Employees

BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases.

Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible.

BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.

Section iconCompany Overview

Headquarters
421 Kipling St Palo Alto, California US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BBIO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
201-500

Section iconFunding & Financials

  • $250M

    BridgeBio has raised a total of $250M of funding over 13 rounds. Their latest funding round was raised on Mar 05, 2024.

  • $50M$100M

    BridgeBio's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $250M

    BridgeBio has raised a total of $250M of funding over 13 rounds. Their latest funding round was raised on Mar 05, 2024.

  • $50M$100M

    BridgeBio's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.